Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Endothermal ablation, foam and surgery concepts

Essential points for quick revision.

Saved on this device
!
Post-procedure thromboembolism

New unilateral swelling, pleuritic chest pain, breathlessness, haemoptysis, syncope or hypoxia after venous intervention may represent deep vein thrombosis or pulmonary embolism.

Action: Stop routine aftercare, assess physiological stability, and enter the appropriate urgent VTE diagnostic pathway; call emergency services for haemodynamic compromise or severe respiratory symptoms.

Synopsis

Choose between endothermal ablation, ultrasound-guided foam sclerotherapy and surgery for truncal venous reflux, while recognising procedural limitations and complications.

  • Confirm symptomatic truncal reflux with duplex before intervention; identify the refluxing target, deep-vein patency and anatomy that may make superficial ablation unsafe or ineffective.
  • For confirmed truncal reflux, NICE offers endothermal ablation first, ultrasound-guided foam sclerotherapy if endothermal treatment is unsuitable, and surgery if foam is unsuitable.
  • Explain that treatment may require more than one session, new or recurrent veins can develop, and post-procedure DVT or PE symptoms require urgent assessment.

Key red flags

Sudden dyspnoea, chest pain, haemoptysis, collapse or marked unilateral swelling after treatment needs urgent assessment for venous thromboembolism.

A cold painful foot, neurological deficit, severe escalating limb pain or tissue discoloration raises concern for arterial injury, compartment syndrome or major extravasation.

After foam injection, an acute focal neurological deficit, seizure, persistent visual loss or altered consciousness requires emergency neurological assessment rather than reassurance as migraine.

Fever, spreading erythema, purulent discharge or systemic illness after an incision or puncture suggests infection and requires prompt clinical review.

Investigation priorities

01
Full lower-limb venous duplex ultrasoundFirst step

Confirm the reflux source, map truncal and tributary anatomy, and establish deep-vein patency before treatment.

Management branches

Treatment selectionConfirmed symptomatic truncal reflux

Use after specialist clinical assessment and duplex have demonstrated a refluxing superficial trunk that explains symptoms or complications.

  1. Offer endothermal ablation when the target can be accessed and treated safely, explaining catheter placement, tumescent anaesthesia, expected discomfort and alternatives.
  2. If endothermal treatment is unsuitable, consider ultrasound-guided foam after checking product contraindications and counselling about pigmentation, phlebitis, VTE, visual and neurological effects.
Endothermal pathwayPreferred endothermal pathway

Use when a suitable refluxing great or small saphenous segment makes catheter-based thermal closure the preferred agreed procedure.

Key medicines

Sodium tetradecyl sulfate foam (Fibrovein 1% or 3%)Inject intravenously in 0.5–2 mL foam aliquots at suitable sites; maximum total foam volume is 16 mL per session. Because volume is limited, repeated sessions are usually needed, with 2 to 4 sessions on average.Specialist ultrasound-guided administration only; for truncular varicosities keep the foam injection site at least 8 to 10 cm from the saphenofemoral junction. Contraindications include recent SVT, DVT or PE, high thrombotic risk, occlusive arterial disease and symptomatic PFO for foam. Postpone in pregnancy; avoid extravasation and intra-arterial injection.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom